tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (SE:VICO)
:VICO
Sweden Market

Vicore Pharma Holding AB (VICO) Income Statement

Compare
0 Followers

Vicore Pharma Holding AB Income Statement

Last quarter (Q4 2024), Vicore Pharma Holding AB's total revenue was kr5.10M, an increase of Infinity% from the same quarter last year. In Q4, Vicore Pharma Holding AB's net income was kr-84.08M. See Vicore Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 109.35Mkr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 109.35Mkr -3.42Mkr -3.61Mkr -3.60Mkr -3.54M
Operating Expenses
kr 303.54Mkr 321.51Mkr 287.49Mkr 293.42Mkr 149.47M
Depreciation and Amortization
kr 25.31Mkr 3.42Mkr 3.61Mkr 3.60Mkr 3.54M
EBITDA
kr -168.88Mkr -317.47Mkr -286.20Mkr -293.13Mkr -143.77M
Operating Income
kr -194.19Mkr -321.51Mkr -290.73Mkr -294.82Mkr -149.54M
Other Income/Expenses
kr 25.30Mkr 10.18Mkr 1.92Mkr -1.92Mkr 2.22M
Pretax Income
kr -168.89Mkr -311.33Mkr -288.81Mkr -296.74Mkr -147.31M
Net Income
kr -168.63Mkr -310.94Mkr -288.42Mkr -296.48Mkr -146.86M
Per Share Metrics
Basic EPS
kr -1.51kr -3.22kr -3.99kr -4.25kr -2.71
Diluted EPS
kr -1.51kr -3.22kr -3.99kr -4.25kr -2.71
Weighted Average Shares Outstanding
111.73M 96.56M 72.21M 69.68M 54.25M
Weighted Average Shares Outstanding (Diluted)
111.73M 96.56M 72.21M 69.68M 54.25M
Currency in SEK

Vicore Pharma Holding AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis